arrow
L

Lykke Larsen

Odense University Hospital
H指数:22
被引数:1,563

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of RSVpreF Vaccination According to Cardio-Kidney-Metabolic Overlap in Older Adults: A DAN-RSV Trial Analysis

根据心肾代谢重叠情况评估RSVpreF疫苗接种效果的老年人群:DAN-RSV试验分析

2026-10-160
OAAI
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Kidney Disease: Insights From 3 Nationwide Randomized Trials

电子提示以提高慢性肾脏病患者流感疫苗接种率:来自3项全国性随机试验的见解

2026-10-140
OAAI
RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial

RSV疫苗预防心力衰竭患者呼吸道和心血管住院:DAN-RSV扩展试验的预先设定分析

2026-09-070
OAAI
Borrelia or Bell’s? Development of BoB: a clinical decision support tool to differentiate Lyme neuroborreliosis facial palsy from Bell’s palsy

博氏疏螺旋体还是贝尔氏?BoB的开发:一种临床决策支持工具,用于区分莱姆神经疏螺旋体面瘫与贝尔氏面瘫

2026-09-010
OAAI
High-dose vs. standard-dose influenza vaccine in heart failure: the FLUNITY-HD trial

高剂量与标准剂量流感疫苗在心力衰竭中的应用:FLUNITY-HD试验

2026-08-290
OAAI
Effectiveness of High-Dose versus Standard-Dose Influenza Vaccine against Venous Thromboembolic Events: A Post Hoc Analysis of the DANFLU-2 Trial

高剂量与标准剂量流感疫苗对静脉血栓栓塞事件的预防效果:DANFLU-2试验的事后分析

2026-08-280
OAAI
Torque Teno Virus Viral Load as a Predictive Marker of Serotype-Specific Antibody Response Following the 13-Valent Conjugated Pneumococcal Vaccine in Adult Kidney Transplant Recipients: A Cohort Study

托诺病毒载量作为13价结合肺炎球菌疫苗在成人肾移植受者中血清型特异性抗体反应的预测标志物:一项队列研究

2026-04-270
PRE
Electronic Nudges to Increase Influenza Vaccination in Immunosuppressed Adults Across the Age Spectrum: A Pooled Analysis of Two Nationwide Randomized Trials

电子助推以提高免疫抑制成年人的季节性流感疫苗接种率:两项全国性随机试验的合并分析

2026-04-120
PRE
Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial

对心房颤动年轻及中年个体通过电子提醒提高流感疫苗接种率:NUDGE-FLU-CHRONIC试验的预先指定分析

2026-01-010
PRE
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease

高剂量与标准剂量流感疫苗在慢性肾脏疾病中的应用

JACC
IF0
2025-11-260
OAAI
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Atrial Fibrillation

高剂量与标准剂量流感疫苗在房颤老年患者中的应用比较

JACC
IF0
2025-11-260
OAAI
Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases
2025-11-012
PRE
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis

高剂量流感疫苗对老年人住院的疗效(FLUNITY-HD):一项基于个体水平的合并分析

2025-10-170
PRE
Effect of RSV Vaccine on Heart Failure Hospitalizations

RSV疫苗对心力衰竭住院的影响

JACC
IF0
2025-08-300
PRE
Nonoperative Versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested Within a Nationwide, Population-Based Cohort

非手术治疗与神经外科治疗脑脓肿的比较:一项在全国性、基于人群的队列中嵌套的模拟试验

2025-08-011
PRE
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial

二价呼吸道合胞病毒前融合F蛋白疫苗在有无动脉粥样硬化性心血管疾病个体中的有效性:DAN-RSV试验

2025-08-012
OAAI
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial

高剂量与标准剂量灭活流感疫苗及在有无原有动脉粥样硬化性心血管疾病人群中心血管结局:DANFLU-2试验

2025-08-012
OAAI
A Pragmatic Individually Randomized Trial to Evaluate the Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccine in Older Adults: Rationale and Design of the DANFLU-2 Trial

一项实用型个体随机对照试验,旨在评估高剂量与标准剂量流感疫苗在老年人群中的有效性:DANFLU-2试验的原理与设计

2025-07-300
OAAI
A Pragmatic Individually Randomized Trial to Evaluate Bivalent RSV Prefusion F Protein–based Vaccine Effectiveness for Preventing RSV Hospitalizations in Adults Aged 60 Years or Above (DAN-RSV): Rationale & Trial Design

一项实用性个体随机试验,旨在评估双价RSV预融合F蛋白疫苗对预防60岁及以上成人RSV住院的有效性(DAN-RSV):研究依据与试验设计

2025-07-280
OAAI